107 related articles for article (PubMed ID: 32040154)
21. Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials.
Suri RS; Larive B; Garg AX; Hall YN; Pierratos A; Chertow GM; Gorodetskeya I; Kliger AS;
Nephrol Dial Transplant; 2011 Jul; 26(7):2316-22. PubMed ID: 21421590
[TBL] [Abstract][Full Text] [Related]
22. Which outcomes should we measure in adult epilepsy trials? The views of people with epilepsy and informal carers.
Noble AJ; Marson AG
Epilepsy Behav; 2016 Jun; 59():105-10. PubMed ID: 27123531
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Outcomes Reported in Hemodialysis Trials.
O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Roy D; Herrington WG; Herzog CA; Jafar T; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Webster AC; Wheeler DC
J Am Coll Cardiol; 2018 Jun; 71(24):2802-2810. PubMed ID: 29903353
[TBL] [Abstract][Full Text] [Related]
24. A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.
Cabrera C; Brunelli SM; Rosenbaum D; Anum E; Ramakrishnan K; Jensen DE; Stålhammar NO; Stefánsson BV
BMC Nephrol; 2015 Jul; 16():113. PubMed ID: 26197758
[TBL] [Abstract][Full Text] [Related]
25. Association of plasma macrophage colony-stimulating factor with cardiovascular morbidity and all-cause mortality in chronic hemodialysis patients.
Deng X; Yang Q; Wang Y; Yang Y; Pei G; Zhu H; Wu J; Wang M; Zhao Z; Xu H; Zhou C; Guo Y; Yao Y; Zhang Z; Liao W; Zeng R
BMC Nephrol; 2019 Aug; 20(1):321. PubMed ID: 31419967
[TBL] [Abstract][Full Text] [Related]
26. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.
Suzuki H; Kanno Y; Sugahara S; Ikeda N; Shoda J; Takenaka T; Inoue T; Araki R
Am J Kidney Dis; 2008 Sep; 52(3):501-6. PubMed ID: 18653268
[TBL] [Abstract][Full Text] [Related]
27. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
Lu W; Jiang GR;
BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
[TBL] [Abstract][Full Text] [Related]
28. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.
Slinin Y; Greer N; Ishani A; MacDonald R; Olson C; Rutks I; Wilt TJ
Am J Kidney Dis; 2015 Nov; 66(5):823-36. PubMed ID: 26498415
[TBL] [Abstract][Full Text] [Related]
29. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney.
Chen SJ; Jiang GR; Shan JP; Lu W; Huang HD; Ji G; Wu P; Wu GF; Wang W; Zhu C; Bian F
Int J Artif Organs; 2011 Apr; 34(4):339-47. PubMed ID: 21534244
[TBL] [Abstract][Full Text] [Related]
30. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
Refaat H; Sany D; Mohab A; Ezzat H
Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
[TBL] [Abstract][Full Text] [Related]
31. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.
Obokata M; Negishi K; Sunaga H; Ishida H; Ito K; Ogawa T; Iso T; Ando Y; Kurabayashi M
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974498
[TBL] [Abstract][Full Text] [Related]
32. Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchers.
Tikellis G; Tong A; Lee JYT; Corte TJ; Hey-Cunningham AJ; Bartlett M; Crawford T; Glaspole I; Price J; Maloney J; Holland AE
Thorax; 2021 Jun; 76(6):575-581. PubMed ID: 33277429
[TBL] [Abstract][Full Text] [Related]
33. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
34. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of heart rate variability in patients with renal failure on hemodialysis.
Oikawa K; Ishihara R; Maeda T; Yamaguchi K; Koike A; Kawaguchi H; Tabata Y; Murotani N; Itoh H
Int J Cardiol; 2009 Jan; 131(3):370-7. PubMed ID: 18199499
[TBL] [Abstract][Full Text] [Related]
36. Email for clinical communication between patients/caregivers and healthcare professionals.
Atherton H; Sawmynaden P; Sheikh A; Majeed A; Car J
Cochrane Database Syst Rev; 2012 Nov; 11():CD007978. PubMed ID: 23152249
[TBL] [Abstract][Full Text] [Related]
37. Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients.
Hu Z; Zhu F; Zhang N; Zhang C; Pei G; Wang P; Yang J; Guo Y; Wang M; Wang Y; Yang Q; Zhu H; Liao W; Zhang Z; Yao Y; Zeng R; Xu G
PLoS One; 2017; 12(3):e0172490. PubMed ID: 28267753
[TBL] [Abstract][Full Text] [Related]
38. Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey.
Chevance A; Ravaud P; Tomlinson A; Le Berre C; Teufer B; Touboul S; Fried EI; Gartlehner G; Cipriani A; Tran VT
Lancet Psychiatry; 2020 Aug; 7(8):692-702. PubMed ID: 32711710
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis.
Yang Y; Li W; Zhu H; Pan XF; Hu Y; Arnott C; Mai W; Cai X; Huang Y
BMJ; 2020 May; 369():m1184. PubMed ID: 32381490
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
